Towards comprehensive clinical trials for new tuberculosis drug regimens: policy recommendations from a stakeholder analysis

Background Research and development (R&D) of new drugs and regimens against tuberculosis (TB) is evolving to meet new challenges and face limited investments in the sector. To effectively improve and fill existing gaps, researchers and trialists should engage a broad spectrum of stakeholders...

Full description

Bibliographic Details

Published in:	BMJ Global Health
Main Authors:	Mario Raviglione, Simone Villa, Pierpaolo de Colombani, Lucia Dall’Olio, Giuliano Gargioni
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-04-01
Online Access:	https://gh.bmj.com/content/9/4/e014630.full